Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
Geomagnetic disturbance: A new field in multiple sclerosis research.
Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Diagnostic Utility of Systematic Aquaporin-4 Antibodies Determination in the First Event of Immune-Mediated Optic Neuritis.
Healthy Life-Years Lost and Excess Bed-Days Due to 6 Patient Safety Incidents: Empirical Evidence From English Hospitals.
"A new imaging modality to non-invasively assess multiple sclerosis pathology".
Adverse Structural and Functional Effects of Marijuana on the Brain: Evidence Reviewed.
Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.
Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
Three cases of neuromyelitis optica spectrum disorder.
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
Neurogenic bowel dysfunction translation and linguistic validation to classical Arabic.
Poster 362 Osmotic Demyelination in Lyme Disease: A Case Report.
The Three Sisters of Fate in Multiple Sclerosis: Klotho (Clotho), Fibroblast Growth Factor-23 (Lachesis), and Vitamin D (Atropos).
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Investigation of cerebral microbleeds in multiple sclerosis as a potential marker of blood-brain barrier dysfunction.
Inflammation severely alters thyroid hormone signaling in the central nervous system during experimental allergic encephalomyelitis in rat: Direct impact on OPCs differentiation failure.
Exercise and Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
Therapeutic developments for autoimmune demyelinating diseases: Musing from an MD (mouse doctor).
Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
Self-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS Registry.
Multiple sclerosis: Biomarkers and genetic variants reflect disease course in multiple sclerosis.
Pages
« first
‹ previous
…
850
851
852
853
854
855
856
857
858
…
next ›
last »